Question & AnswerQ&A (EXECUTIVE ORDER NO. 49)
The main purpose is to mandate the use of the Philippine National Drug Formulary (PNDF) Volume I as the basis for the procurement of drug products by all government entities to promote rational drug use and comply with health policies.
All government entities concerned are mandated to use the current PNDF (Volume I) as the basis for procurement of drug products.
Section 15, Article II; Sections 11 and 12, Article XIII of the 1987 Constitution which emphasize the protection and promotion of public health, provision of essential goods and services at affordable cost, and the establishment of an effective food and drug regulatory system.
The Core List, which includes essential drugs needed by the majority of the population and should always be available; and the Complementary List, which includes drugs for rare disorders, special pharmaceuticals, or alternative drugs when Core List drugs are not effective or cannot be administered.
The Therapeutic Committee, Physician-in-Charge of the Clinic or Infirmary, or the Procurement Officer, whichever is applicable.
A certification signed by the requisitioning officer stating that the drug products being requisitioned or procured conform with the current edition of the PNDF Volume I.
The COA instructs auditors to monitor compliance and disallow claims or disbursements for procurement of drugs not listed in the PNDF Volume I.
A written request with justification must be submitted to the Head of the National Drug Policy Office who may approve or disapprove it; the request may be referred to the National Drug Committee for evaluation.
Violations are considered conduct grossly prejudicial to the best interest of the service or grave misconduct under P.D. 807 and CSC-M No. 30, s. 1989.
The Generics Act of 1988 encourages the use of drugs with generic names through a rational procurement and distribution system, emphasizing scientific basis and therapeutic effectiveness.